Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER
Close

BioLineRx Ltd (BLRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow BioLineRx's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.705 +0.004    +0.50%
30/11 - Closed. Currency in USD ( Disclaimer )
Pre Market
0.718
+0.013
+1.844%
8:00:01 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 311,435
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.681 - 0.720
BioLineRx 0.705 +0.004 +0.50%

BLRX Balance Sheet

 
Featured here, the Balance Sheet for BioLineRx Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets 57.94 44.1 50.94 57.4
Cash and Short Term Investments 57.26 43.15 50.59 57.14
Cash - - - -
Cash & Equivalents 13.1 14 11.45 12.99
Short Term Investments 44.16 29.15 39.14 44.14
Total Receivables, Net 0.143 0.24 0.19 0.142
Accounts Receivables - Trade, Net - - - -
Total Inventory - - - -
Prepaid Expenses 0.537 0.717 0.161 0.127
Other Current Assets, Total - - - -
Total Assets 81.67 67.84 74.77 81.39
Property/Plant/Equipment, Total - Net 2.02 2.03 2.13 2.28
Property/Plant/Equipment, Total - Gross - - - 6.82
Accumulated Depreciation, Total - - - -4.54
Goodwill, Net - - - -
Intangibles, Net 21.72 21.7 21.7 21.7
Long Term Investments - - - -
Note Receivable - Long Term 0.143 0.24 0.19 0.142
Other Long Term Assets, Total - - - -
Other Assets, Total 44.01 28.91 38.95 44
Total Current Liabilities 8.13 9.63 9.1 9.72
Accounts Payable 5.83 7.34 5.78 5.57
Payable/Accrued - - 1.26 1.23
Accrued Expenses - - - 1.22
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.953 1.16 2.05 2.92
Other Current liabilities, Total 1.35 1.13 1.26 0.002
Total Liabilities 26.15 11.27 11.36 13.3
Total Long Term Debt 9.86 1.45 1.66 1.73
Long Term Debt 8.35 - - -
Capital Lease Obligations 1.51 1.45 1.66 1.73
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 8.16 -0.827 -1.3 -0.898
Total Equity 55.52 56.57 63.41 68.09
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 27.1 21.16 21.07 21.07
Additional Paid-In Capital 338.84 339.67 339.44 339.35
Retained Earnings (Accumulated Deficit) -324.26 -317.41 -309.97 -305.04
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 13.85 13.16 12.87 12.72
Total Liabilities & Shareholders' Equity 81.67 67.84 74.77 81.39
Total Common Shares Outstanding 715.16 718.28 715.16 715.16
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BLRX Comments

Write your thoughts about BioLineRx Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Benjamin Kumpfmueller
Benjamin Kumpfmueller Sep 12, 2022 10:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BioLineRx Announces Submission of New Drug Application (NDA) to FDA for Motixafortide in Stem Cell Mobilization
Jul 06, 2021 7:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They get fda fast track!!!
Greg Heal
Greg Heal Jul 01, 2021 10:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now it looks like my lucky ticket to the moon 🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝🌝
Vitor Bdo
Vitor Bdo Jun 30, 2021 4:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get ready for the plane's take-off.
Samir Naik
Samir Naik May 14, 2021 5:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I will not be a surprise, if this stock goes with 3 digit figures in the long run. lots of potential is hidden and should bustout anytime.
Samir Naik
Samir Naik May 14, 2021 5:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
journey begins...
Zoran Labus
Zoran Labus May 12, 2021 6:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.tipranks.com/stocks/blrx/forecast
mordecai nadav
mordecai nadav May 07, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do they really had good results ?The stock behavior say otherwise
MR Hunter
MR Hunter May 06, 2021 3:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they will file for approval early next year, hopefully this will help it pick up again
Tariq Matloob
Tariq Matloob May 04, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BioLine RX rockets on heavy volume after 'strikingly positive' trial data on cancer treatment
Dong ThreeThousand
Dong ThreeThousand May 04, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any chance that the result was overrated? How is us market reacting to the results?
Benjamin Kumpfmueller
Benjamin Kumpfmueller May 04, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moshe Ohr
Moshe Ohr May 04, 2021 11:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
If so this can hit $30 with ease
Giuseppe Giannachi
Giuseppe Giannachi May 04, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Only me?
Dong ThreeThousand
Dong ThreeThousand May 04, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What r the reactions to the news? On US?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email